CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
75. 63
-1.12
-1.46%
$
101.38B Market Cap
11.4 P/E Ratio
2.66% Div Yield
5,858,041 Volume
7.87 Eps
$ 76.75
Previous Close
Day Range
74.98 76.86
Year Range
43.56 85.15
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days
Has CVS Health Stock Turned Things Around?

Has CVS Health Stock Turned Things Around?

Last year, shares of healthcare company CVS Health (CVS 1.92%) crashed by more than 43%. The company struggled with rising medical costs and routinely missed earnings expectations.

Fool | 9 months ago
The Smartest Dividend Stocks to Buy With $3,000 Right Now

The Smartest Dividend Stocks to Buy With $3,000 Right Now

So you've got $3,000 -- or perhaps just $300 or maybe $30,000 -- to invest and you want to park that money in dividend-paying stocks as you've paid off all your high-interest debt, have plumped up your emergency savings, and won't need the money for anything in the near or medium term. That's very smart of you!

Fool | 9 months ago
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?

Is Trending Stock CVS Health Corporation (CVS) a Buy Now?

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 9 months ago
CVS cuts bonuses after low profit levels in 2024

CVS cuts bonuses after low profit levels in 2024

CVS Health said on Friday it has cut bonuses for some employees because of its low profit levels last year, as the healthcare conglomerate grapples with higher costs across its Medicare plans.

Reuters | 9 months ago
This stock is up 50% already since Jim Cramer's warning

This stock is up 50% already since Jim Cramer's warning

Jim Cramer, the eccentric host of ‘Mad Money' on CNBC, is one of the most recognizable voices covering finance in the United States. Recognizable, however, does not necessarily equate to reverence.

Finbold | 9 months ago
Top 2 cheap stocks to buy for 2025

Top 2 cheap stocks to buy for 2025

The US consumer price index (CPI) was up more than expected in January, raising doubts about the Federal Reserve's ability to lower interest rates further in 2025.

Invezz | 9 months ago
CVS Health: One Good Quarter Is Not Enough; Retain Sell

CVS Health: One Good Quarter Is Not Enough; Retain Sell

Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage levels. CVS' Q4 results showed a surprising EBIT margin beat, but continued margin erosion in its insurance business remains a concern. Improved margin performance in FY25 is possible with better insurance policy terms and reduced loss-making membership counts but given a poor execution record, it is better to wait for evidence.

Seekingalpha | 9 months ago
Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?

Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?

After underperforming throughout 2024, shares of CVS Health (CVS -0.81%) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher.

Fool | 9 months ago
CVS Health Post-Q4 Earnings: Is the Stock Worth Buying Now?

CVS Health Post-Q4 Earnings: Is the Stock Worth Buying Now?

CVS Health's adjusted EPS outlook for 2025 reflects expectations of a meaningful recovery in Medicare Advantage and continued growth in Health Services.

Zacks | 9 months ago
Why CVS Stock Thrashed the Market on Thursday

Why CVS Stock Thrashed the Market on Thursday

For the second day in a row, CVS Health's (CVS 4.98%) stock price saw a satisfying jump on Thursday. It closed the day almost 5% higher, on the back of both lingering optimism and news of another in a series of analyst price target raises.

Fool | 9 months ago
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock

On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.

Benzinga | 9 months ago
CVS shares are up 45% this year — here's why it may be starting to turn its business around

CVS shares are up 45% this year — here's why it may be starting to turn its business around

CVS Health could be starting to turn itself around after a dismal 2024. Its shares are up more than 45% this year, outperforming pharmacy rival Walgreens and other insurers like UnitedHealth Group and Cigna.

Cnbc | 9 months ago
Loading...
Load More